Sea buckthorn supplement to improve bowel function in primary functional constipation
Official title: Efficacy and Tolerability of a Food Supplement Based on a Sea Buckthorn (Hippophae Rhamnoides L.) Extract Taken at Two Different Doses for the Management of Balance in Bowel Function in Subjects With Primary Functional Constipation: Single-center, Randomized, Placebo-controlled, Parallel-arm, Double-blind Clinical Trial
Run by Istituto Farmochimico Fitoterapico: Epo Srl · NCT07082673 · Data updated 2026-11-12
This study will test whether a sea buckthorn (Hippophae rhamnoides) supplement at two different doses helps adults with primary functional constipation have more frequent, softer bowel movements and less bloating.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 135 (estimated) |
| Sponsor | Istituto Farmochimico Fitoterapico: Epo Srl Industry-sponsored |
| Locations | 1 site (Naples) |
| Status | Recruiting |
| Started | July 24, 2025 |
| Main results expected | September 2025 |
| Study ends | September 2025 |
| Registry record updated | July 30, 2025 |
| Trial ID | NCT07082673 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with primary functional constipation (chronic symptoms for ≥3 months, onset ≥6 months earlier, and ≤3 SCBMs per week with supporting symptom criteria) who can consent and attend the study site.
✕Probably not a fit
Patients who are pregnant, breastfeeding, HIV positive, have predominant abdominal pain suggestive of IBS-C, or have secondary causes of constipation are unlikely to qualify or benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled trial will assign 135 adults with primary functional constipation into three parallel groups (45 per group) to receive sea buckthorn extract 500 mg, 1500 mg, or placebo. Participants are adults aged 18–70 with chronic constipation symptoms and fewer than three spontaneous complete bowel movements per week. The primary outcome is change in spontaneous complete bowel movements (SCBM) frequency; secondary outcomes include stool consistency by the Bristol Stool Form Scale and typical constipation symptoms (bloating, abdominal distension, pain, flatulence) and quality of life. The trial uses standardized dosing and blinded allocation to compare efficacy and tolerability of the supplement versus placebo.
Why it matters
Potential benefit: If successful, the supplement could offer a well-tolerated, plant-based option to increase bowel movement frequency and reduce constipation symptoms.
How similar studies have gone: Some small clinical and preclinical studies and traditional use suggest sea buckthorn may improve intestinal motility and stool hydration, but high-quality randomized evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged between 18 and 70 years * able to understand and sign informed consent * HIV negative test * negative pregnancy test * with symptoms of chronic constipation for at least 3 months (with onset at least 6 months earlier) * absent/non-predominant abdominal pain that occurs less than one day per week and, therefore, not affected by IBS-C * who have less than three SCBWs per week and at least one of the following conditions: * in more than 25%\* of defecatory acts * lumpy or hard stools (BSFS type 1 or 2) in more than 25% of bowel movements * feeling of incomplete evacuation in more than 25% of defecations * feeling of anorectal obstruction/blockage in more than 25% of defecations * carry out manual manoeuvres to facilitate evacuation in more than 25% of defecations * able to understand and comply with the requirements of the protocol Exclusion Criteria: * pregnancy * lactation * HIV positive * do not meet inclusion criteria.
Where it's running
-
COMEGEN Soc. Coop. Sociale
Naples, Italy Recruiting
Study contacts
- Study coordinator: Alessandra Baldi
- Email: alessandra.baldi.alimenti@gmail.com
- Phone: +393483854114
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fiber supplement plus counseling for constipation during pregnancy
A daily fiber supplement (PHGG-based) with vitamin mix and nutrition counseling is being tested to see if it helps pregnant people with functional constipation.
-
Comparing manual and electroacupuncture for functional constipation
This trial will try manual acupuncture and electroacupuncture to see which produces more complete spontaneous bowel movements in adults with functional constipation.
-
Brain stimulation (tACS) for adults with stubborn constipation and somatic symptom disorder
We will test whether four weeks of gentle brain stimulation (tACS) can improve bowel movements and symptoms in adults with refractory functional constipation and somatic symptom disorder.
-
Probiotics for treating constipation in adults
This study is testing if a probiotic called ABKefir can help adults with constipation feel better after 8 weeks of treatment.
-
Probiotic treatment for constipation in pregnant women
This study tests if a probiotic and a special liquid can help pregnant women with constipation feel better and improve their gut health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.